Literature DB >> 12746142

A role for P-glycoprotein in environmental toxicology.

Aqel W Abu-Qare1, Eman Elmasry, Mohamed B Abou-Donia.   

Abstract

P-Glycoprotein (P-gp) is a transmembrane protein, playing significant roles in the process of drug discovery and development and in pest resistance to pesticides. P-gp affects absorption, disposition, and elimination of different compounds and is mainly expressed in intestines, liver, kidneys, heart, colon, and placenta. The expression of P-gp in the blood-brain barrier (BBB) has been associated with the restricted access of many compounds to the central nervous system. Generated knockout mice by disruption of mdr 1a gene, encoding for P-gp, showed that this protein was expressed in the BBB. The absence or the low levels of P-gp elevated drug concentrations in tissues and decreased drug elimination. P-gp is responsible for resistance of cells to agents, particularly the anticancer drugs, by removing these drugs from cells. Increased expression of P-gp is implicated in decreased HIV drug availability at certain intracellular sites. The role of P-gp in affecting efficacy and toxicity of environmental toxicants such as pesticides and heavy metals has not been adequately investigated. Studies showed that P-gp contributes to resistance to pesticides in certain pest species, and to decrease toxicity by removing compounds from cells in mammals. Placental drug-transporting P-gp plays a significant role in limiting the transport of toxicants such as potential teratogens to the fetus. Several in vitro or in vivo assays, including using P-gp knockout or naturally deficient mice, were described for testing P-gp modulators. The role of P-gp following concurrent exposure to more multiple compounds needs further research. P-gp modulators should be carefully used, since some modulators that reverse P-gp efflux action in vitro may lead to alterations of tissue function and increase toxicity of xenobiotics in normal tissues. Recent reports from the pharmaceutical studies on the significance of P-gp as transporters in altering the efficacy and toxicity clearly highlight the need for further research in interaction with environmental toxicants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746142     DOI: 10.1080/10937400306466

Source DB:  PubMed          Journal:  J Toxicol Environ Health B Crit Rev        ISSN: 1093-7404            Impact factor:   6.393


  16 in total

Review 1.  Efflux transporters as a novel herbivore countermechanism to plant chemical defenses.

Authors:  Jennifer S Sorensen; M Denise Dearing
Journal:  J Chem Ecol       Date:  2006-05-23       Impact factor: 2.626

2.  Non-nutritive sweeteners in breast milk: perspective on potential implications of recent findings.

Authors:  Kristina I Rother; Allison C Sylvetsky; S S Schiffman
Journal:  Arch Toxicol       Date:  2015-10-14       Impact factor: 5.153

Review 3.  ABC drug transporter at the blood-brain barrier: effects on drug metabolism and drug response.

Authors:  Martin Ebinger; Manfred Uhr
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-08       Impact factor: 5.270

4.  Modulatory effects of natural curcuminoids on P-glycoprotein ATPase of insecticide-resistant pest Helicoverpa armigera (Lepidopetera: Noctüidae).

Authors:  Ravindra M Aurade; Senigala K Jayalakshmi; Kuruba Sreeramulu
Journal:  J Membr Biol       Date:  2010-09-04       Impact factor: 1.843

5.  Fetal polymorphisms at the ABCB1-transporter gene locus are associated with susceptibility to non-syndromic oral cleft malformations.

Authors:  Ardeshir Omoumi; Zihua Wang; Vincent Yeow; Yah-Huei Wu-Chou; Philip K Chen; Ingo Ruczinski; Joanne Cheng; Felicia S H Cheah; Caroline G Lee; Terri H Beaty; Samuel S Chong
Journal:  Eur J Hum Genet       Date:  2013-02-27       Impact factor: 4.246

6.  Assessment of the disposition of chiral polychlorinated biphenyls in female mdr 1a/b knockout versus wild-type mice using multivariate analyses.

Authors:  Bartłomiej Milanowski; Janina Lulek; Hans-Joachim Lehmler; Izabela Kania-Korwel
Journal:  Environ Int       Date:  2009-11-17       Impact factor: 9.621

7.  Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resistant human colon carcinoma LoVo/5-FU cells.

Authors:  Zhi-Wei Yu; Peng Zhao; Ming Liu; Xin-Shu Dong; Ji Tao; Xue-Qin Yao; Xin-Hua Yin; Yu Li; Song-Bin Fu
Journal:  World J Gastroenterol       Date:  2004-07-01       Impact factor: 5.742

Review 8.  Pathophysiological implications of neurovascular P450 in brain disorders.

Authors:  Chaitali Ghosh; Mohammed Hossain; Jesal Solanki; Aaron Dadas; Nicola Marchi; Damir Janigro
Journal:  Drug Discov Today       Date:  2016-06-14       Impact factor: 7.851

9.  Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.

Authors:  Vibeke Andersen; Katrine Svenningsen; Lina Almind Knudsen; Axel Kornerup Hansen; Uffe Holmskov; Allan Stensballe; Ulla Vogel
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

10.  Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study.

Authors:  Vibeke Andersen; Mette Ostergaard; Jane Christensen; Kim Overvad; Anne Tjønneland; Ulla Vogel
Journal:  BMC Cancer       Date:  2009-11-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.